| Structure |
Chemical Name |
CAS |
MF |
 |
Ticagrelor Impurity 63 |
2227766-79-0 |
C9H9ClFN |
 |
Canagliflozin Impurity 5 |
|
|
|
|
Canagliflozin Impurity 15 |
|
|
|
|
Oseltamivir Impurity 31 |
|
|
|
|
Riociguat IMpurtiy C |
|
|
|
|
Aclidinium Bromide Impurity 1 |
|
|
|
|
Ampicillin Impurity 7 |
|
|
 |
Meropenem impurity diastereomer 1 |
96035-27-7 |
C15H19N3O5S |
 |
methyl 4-hydroxy-6-phenoxyisoquinoline-3-carboxylate |
1509958-11-5 |
C17H13NO4 |
 |
Palbociclib-012 |
2206135-30-8 |
C41H55N11O5 |
![(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone](/CAS/20211123/GIF/858127-38-5.gif) |
(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
858127-38-5 |
C26H32O12 |
|
|
Tigecycline Impurity E |
|
|
|
|
Cefminox Impurity B |
|
|
 |
isopropyl 4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl) benzenesulfonate |
|
C20H19F3N2O3S |
 |
N-(2-HYDROXYETHYL)ISONICOTINAMIDE, 99 |
6265-74-3 |
C8H10N2O2 |
 |
BENAZEPRIL RELATED COMPOUND G (15 MG) ((3-(1 -ETHOXYCARBONYL-3-PHENYL-(1 S)-PROPYL)AMINO-2,3,4,5-TETRAHYDRO-2-OXO-1H-1-(3S)-BENZAZE-PINE)-1-ACETIC ACID, ETHYL ESTER) |
103129-58-4 |
C26H32N2O5 |
 |
Pramipexole EP Impurity E |
106006-84-2 |
C10H15N3OS |
 |
3-Morpholinone, 4-phenyl- |
29518-11-4 |
C10H11NO2 |
|
|
Bumetanide Impurity 3 |
|
|
|
|
Cefoxitin EP Impurity F (S-methoxy cefoxitin) |
|
|
|
|
((((3R,6S)-6-carbamoylpiperidin-3-yl)(ethoxycarbonyl)amino)oxy)sulfonic acid |
|
|
 |
INDEX NAME NOT YET ASSIGNED |
2514949-81-4 |
C20H28N4O2 |
![alpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcohol](/CAS/GIF/748-97-0.gif) |
alpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcohol |
748-97-0 |
C26H31NO2 |
|
|
Brivaracetam Impurity 53 |
|
|
![ethyl hydrogen [R-(R*,R*)]-tartrate](/CAS/GIF/608-89-9.gif) |
ethyl hydrogen [R-(R*,R*)]-tartrate |
608-89-9 |
C6H10O6 |
 |
ethyl 2,2,4-trichloro-3-oxobutyrate |
85153-67-9 |
C6H7Cl3O3 |
|
|
Neodigoxin |
55576-67-5 |
C41H64O14 |
|
|
(S)-6-((R)-2-amino-2-phenylacetamido)-2,2-dimethyl-7-oxo-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxylic acid |
|
|
 |
(R,R)-Palonosetron N-Oxide |
|
C19H24N2O2 |
 |
Desacetylvinblastine hydrazide |
55383-37-4 |
C43H56N6O7 |
 |
4-hydroxypyrrolidin-2-one |
96820-00-7 |
C4H7NO2 |
 |
glycopyrronium bromide |
475468-09-8 |
C19H28NO3.Br |
 |
4'-hydroxyflurbiprofen |
52807-12-2 |
C15H13FO3 |
 |
D-biotin-d-sulfoxide |
10406-89-0 |
C10H16N2O4S |
 |
3,4-dihydroxyphenylpyruvic acid |
4228-66-4 |
C9H8O5 |
 |
delta(3)-cefotiam |
142182-63-6 |
C18H23N9O4S3 |
 |
alpha-(chloromethyl)-2-hydroxymethyl-5-nitroimidazole-1-ethanol |
62580-79-4 |
C7H10ClN3O4 |
 |
4-hydroxypenicillin V |
20880-67-5 |
C16H18N2O6S |
 |
BENAZEPRILAT |
86541-78-8 |
C22H24N2O5 |
 |
9-Methylene-9H-fluorene |
4425-82-5 |
C14H10 |
 |
2-PIPERIDIN-4-YL-1H-BENZOIMIDAZOLE |
38385-95-4 |
C12H15N3 |
 |
4-CHLORO-3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL |
142885-96-9 |
C8H9Cl2N |
 |
9-DIHYDROESTRADIOL |
791-69-5 |
C18H22O2 |
 |
H 128/80 |
29122-74-5 |
C13H19NO3 |
 |
4’-Hydroxy Atomoxetine -D-Glucuronide |
540729-08-6 |
C23H29NO8 |
 |
Decarboxy Ciprofloxacin |
105394-83-0 |
C16H18FN3O |
 |
Zolpidem 6-Carboxylic Acid |
109461-15-6 |
C19H19N3O3 |
 |
Myricetin 3-β-D-glucopyranoside |
19833-12-6 |
C21H20O13 |
 |
2,4,5-Trifluoro-3-methoxybenzoyl chloride |
112811-66-2 |
C8H4ClF3O2 |
 |
1-(Dimethoxymethyl)-2-methoxybenzene |
58378-33-9 |
C10H14O3 |
 |
N-(2-BENZOYL-4-CHLOROPHENYL)FORMAMIDE |
10352-28-0 |
C14H10ClNO2 |
 |
Benzylpenicillin EP Impurity |
5985-13-7 |
C16H19N2NaO5S |
 |
4,4,4-TRIFLUORO-1-(3-METHYLPHENYL)-1,3-BUTANEDIONE |
53764-99-1 |
C11H9F3O2 |
 |
DU 6856 |
127254-11-9 |
C19H18ClF2N3O3 |
 |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
 |
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
![(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate](/CAS/20150408/GIF/929693-31-2.gif) |
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate |
929693-31-2 |
C15H28N2O6S |
 |
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxaMide |
417724-81-3 |
C11H10N2O3 |
 |
MILRINONE RELATED COMPOUND A (50 MG) (1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CAR-BOXAMIDE) |
80047-24-1 |
C12H11N3O2 |
|
|
PREDNICARBATE IMPURITY F |
|
|
![[R(R*,R*]-2-amino-1-[p-(methylsulphonyl)phenyl]propane-1,3-diol](/CAS/GIF/51458-28-7.gif) |
[R(R*,R*]-2-amino-1-[p-(methylsulphonyl)phenyl]propane-1,3-diol |
51458-28-7 |
C10H15NO4S |
 |
16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate |
77017-20-0 |
C23H28O6 |
 |
Pyrimidine, 4-chloro-5-nitro-2-(propylthio)- |
2518331-26-3 |
C7H8ClN3O2S |
|
|
Oseltamivir Impurity 110 |
|
|
|
|
Oseltamivir Impurity 108 |
|
|
|
|
Oseltamivir Impurity 102 |
|
|
 |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- |
2606144-45-8 |
C16H18N6O |
 |
4-Piperidinecarboxylic acid, 1-(4-pyridinylcarbonyl)-, ethyl ester |
252263-38-0 |
C14H18N2O3 |
|
|
(S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
 |
1,4-bis(4-nitrophenyl)piperazine |
16264-05-4 |
C16H16N4O4 |
 |
di(2,4-xylyl) disulphide |
13616-83-6 |
C16H18S2 |
 |
3-acetamidophthalic acid |
15371-06-9 |
C10H9NO5 |
 |
Dexamethasone EP Impurity E |
13209-41-1 |
C22H28O4 |
 |
6-amino-5-formamido-1,3-dimethyluracil |
7597-60-6 |
C7H10N4O3 |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129815-82-3.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI) |
129815-82-3 |
C18H20FN3O4 |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
 |
1,3-diisopropylurea |
4128-37-4 |
C7H16N2O |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
|
|
monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
|
|
Cefradine Impurity J |
|
|
|
|
Peramivir diacetyl impurity 1 |
|
|
|
|
Urapidil Impurity 17 |
|
|
|
|
Clindamycin Impurity 86 |
|
|
|
|
Canagliflozin Impurity 77 |
|
|
|
|
Carbazochrome Sodium Sulfonate Impurity I |
|
|
|
|
Tadalafil impurities 45 |
|
|
|
|
Posaconazole Impurities 10 Complete Set |
|
|
|
|
Cetrorelix Impurity 18 |
|
|
|
|
Cetrorelix Impurity 13 |
|
|
|
|
Bortezomib Impurity G Full Set Pre- |
|
|
|
|
Cetrorelix Impurity 2 (+L-Ser) |
|
|
|
|
Peramivir Intermediate Impurity 39 |
|
|
|
|
Peramivir Intermediate Impurity 59 |
|
|
|
|
Criborole impurity 999 |
|
|
|
|
Atracurium impurity O drops |
|
|
|
|
Pemetrexed Disodium Impurity 21-30 |
|
|
|
|
Bimatoprost Impurity 2 |
|
|
 |
Guanosine |
30747-23-0 |
C18H21N5O9 |
|
|
Minoxidil Impurity G |
|
|